AEterna Zentaris Announces 2004 Fourth Quarter and Full Year Financial Results Conference Call and Webcast
February 22 2005 - 7:31AM
PR Newswire (US)
AEterna Zentaris Announces 2004 Fourth Quarter and Full Year
Financial Results Conference Call and Webcast QUEBEC CITY, Feb. 22
/PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq:
AEZS) announced that its quarterly conference call and webcast have
been scheduled for Monday, February 28, 2005 at 10:00 a.m. Eastern
time. The call will follow the press release of AEterna Zentaris'
2004 fourth quarter and full year financial results issued earlier
on the same day. Participants may access the live webcast via the
Company's website at http://www.aeternazentaris.com/ in the
"investors" section, or by telephone using the following numbers:
416-640-4127, 514-807-8791 or 1-800-814-4941. A replay of the
webcast will also be available on the website for a period of 30
days. AEterna Zentaris Inc. is an oncology and endocrine therapy
focused biopharmaceutical company with proven expertise in drug
discovery, development and commercialization. The Company's broad
20 product pipeline leverages five different therapeutic
approaches, including LHRH antagonists and signal transduction
inhibitors. DATASOURCE: AETERNA ZENTARIS INC.
(FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNA CONTACT: Media
Relations: Paul Burroughs, (418) 652-8525 ext. 406, ; Investor
Relations: Ginette Vallieres, (418) 652-8525, ext. 265, ; Europe:
Matthias Seeber, +49 69 42602 3425, ; To request a free copy of
this organization's annual report, please go to
http://www.newswire.ca/ and click on reports@cnw.
Copyright